 Paul MacLean
Concepts (577)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 56 | 2025 | 3000 | 5.100 |
Why?
| | Weight Gain | 26 | 2023 | 537 | 4.550 |
Why?
| | Energy Metabolism | 32 | 2024 | 930 | 4.400 |
Why?
| | Weight Loss | 26 | 2025 | 790 | 4.130 |
Why?
| | Physical Conditioning, Animal | 10 | 2025 | 253 | 2.390 |
Why?
| | Rats, Wistar | 19 | 2024 | 451 | 2.230 |
Why?
| | Energy Intake | 18 | 2025 | 510 | 2.140 |
Why?
| | Dietary Fats | 14 | 2019 | 299 | 1.840 |
Why?
| | Caloric Restriction | 9 | 2025 | 126 | 1.760 |
Why?
| | Ovariectomy | 11 | 2025 | 158 | 1.730 |
Why?
| | Body Weight | 16 | 2024 | 992 | 1.490 |
Why?
| | Lactation | 8 | 2020 | 192 | 1.460 |
Why?
| | Adipose Tissue | 15 | 2022 | 645 | 1.410 |
Why?
| | Appetite | 3 | 2025 | 71 | 1.360 |
Why?
| | Diet, High-Fat | 15 | 2023 | 250 | 1.350 |
Why?
| | Milk, Human | 6 | 2022 | 169 | 1.270 |
Why?
| | Body Composition | 12 | 2024 | 703 | 1.220 |
Why?
| | Rats | 34 | 2024 | 5594 | 1.150 |
Why?
| | Adipocytes | 7 | 2025 | 220 | 1.120 |
Why?
| | Muscle, Skeletal | 20 | 2022 | 1750 | 1.100 |
Why?
| | Ovary | 4 | 2024 | 225 | 1.040 |
Why?
| | Fatty Acids, Omega-6 | 2 | 2017 | 48 | 1.040 |
Why?
| | Diet, Fat-Restricted | 6 | 2015 | 78 | 1.030 |
Why?
| | Animals | 77 | 2025 | 37579 | 0.980 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2017 | 142 | 0.950 |
Why?
| | Lipid Metabolism | 9 | 2017 | 525 | 0.950 |
Why?
| | Motor Activity | 3 | 2019 | 718 | 0.940 |
Why?
| | Appetite Regulation | 2 | 2017 | 32 | 0.870 |
Why?
| | Adaptation, Physiological | 7 | 2018 | 562 | 0.820 |
Why?
| | Biomedical Research | 3 | 2023 | 680 | 0.810 |
Why?
| | Liver | 11 | 2024 | 1815 | 0.800 |
Why?
| | Cholesterol | 5 | 2019 | 404 | 0.780 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 243 | 0.760 |
Why?
| | Fasting | 7 | 2025 | 283 | 0.760 |
Why?
| | Leptin | 8 | 2025 | 238 | 0.760 |
Why?
| | Vasopressins | 3 | 2021 | 60 | 0.750 |
Why?
| | Lipoprotein Lipase | 3 | 2021 | 56 | 0.750 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2023 | 318 | 0.750 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 16 | 0.750 |
Why?
| | Awards and Prizes | 1 | 2023 | 72 | 0.750 |
Why?
| | Overweight | 5 | 2025 | 587 | 0.750 |
Why?
| | Estrogens | 3 | 2018 | 367 | 0.740 |
Why?
| | Eating | 5 | 2022 | 391 | 0.740 |
Why?
| | Lipogenesis | 3 | 2019 | 64 | 0.730 |
Why?
| | Breast Feeding | 5 | 2022 | 442 | 0.730 |
Why?
| | Mammary Neoplasms, Experimental | 3 | 2021 | 68 | 0.710 |
Why?
| | Mammary Glands, Animal | 5 | 2019 | 131 | 0.710 |
Why?
| | Glycoproteins | 5 | 2005 | 358 | 0.690 |
Why?
| | Receptor, Insulin | 3 | 2015 | 94 | 0.680 |
Why?
| | Insulin | 19 | 2022 | 2458 | 0.670 |
Why?
| | Estradiol | 1 | 2024 | 523 | 0.660 |
Why?
| | Exercise | 11 | 2025 | 2108 | 0.650 |
Why?
| | Milk | 5 | 2019 | 123 | 0.630 |
Why?
| | Oxygen Consumption | 5 | 2019 | 714 | 0.630 |
Why?
| | Thermogenesis | 2 | 2019 | 46 | 0.630 |
Why?
| | Physical Exertion | 3 | 2011 | 209 | 0.620 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 214 | 0.620 |
Why?
| | Female | 64 | 2025 | 75540 | 0.610 |
Why?
| | Carrier Proteins | 6 | 2005 | 746 | 0.600 |
Why?
| | Cold Temperature | 2 | 2019 | 196 | 0.600 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2018 | 656 | 0.570 |
Why?
| | Mitochondria, Muscle | 1 | 2019 | 120 | 0.570 |
Why?
| | Menopause | 2 | 2019 | 317 | 0.560 |
Why?
| | Sex Characteristics | 3 | 2021 | 785 | 0.560 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 53 | 0.560 |
Why?
| | Breast Neoplasms | 6 | 2022 | 2235 | 0.550 |
Why?
| | Diet | 10 | 2023 | 1269 | 0.530 |
Why?
| | Adipogenesis | 1 | 2017 | 56 | 0.530 |
Why?
| | Cortical Bone | 1 | 2017 | 19 | 0.530 |
Why?
| | Insulin Resistance | 9 | 2025 | 1218 | 0.520 |
Why?
| | Organic Cation Transport Proteins | 1 | 2017 | 25 | 0.520 |
Why?
| | Adiposity | 5 | 2016 | 518 | 0.520 |
Why?
| | Diet, Reducing | 4 | 2021 | 90 | 0.510 |
Why?
| | Ibuprofen | 1 | 2017 | 83 | 0.510 |
Why?
| | Mice | 34 | 2025 | 18057 | 0.510 |
Why?
| | Metformin | 2 | 2018 | 329 | 0.500 |
Why?
| | Placenta | 1 | 2023 | 764 | 0.490 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 97 | 0.490 |
Why?
| | Supraoptic Nucleus | 1 | 2015 | 4 | 0.490 |
Why?
| | Osteogenesis | 2 | 2017 | 198 | 0.480 |
Why?
| | Bone Density | 1 | 2019 | 495 | 0.470 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 411 | 0.470 |
Why?
| | Fructose | 5 | 2021 | 117 | 0.460 |
Why?
| | Gene Expression Regulation | 9 | 2021 | 2604 | 0.460 |
Why?
| | Oxytocin | 1 | 2015 | 51 | 0.460 |
Why?
| | Intra-Abdominal Fat | 2 | 2022 | 89 | 0.450 |
Why?
| | Therapies, Investigational | 1 | 2014 | 18 | 0.440 |
Why?
| | Mothers | 4 | 2018 | 777 | 0.440 |
Why?
| | Male | 58 | 2025 | 69893 | 0.420 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 348 | 0.420 |
Why?
| | Weight Reduction Programs | 3 | 2025 | 117 | 0.420 |
Why?
| | Fatty Acids | 8 | 2022 | 448 | 0.410 |
Why?
| | Transcription Factors | 12 | 2019 | 1703 | 0.400 |
Why?
| | Basal Metabolism | 3 | 2021 | 63 | 0.400 |
Why?
| | Fructokinases | 5 | 2021 | 35 | 0.400 |
Why?
| | Monosaccharide Transport Proteins | 3 | 2002 | 50 | 0.400 |
Why?
| | Disease Models, Animal | 11 | 2021 | 4407 | 0.390 |
Why?
| | Fatty Liver | 5 | 2018 | 232 | 0.380 |
Why?
| | Overnutrition | 1 | 2012 | 30 | 0.380 |
Why?
| | Humans | 68 | 2025 | 140898 | 0.380 |
Why?
| | Anorexia Nervosa | 1 | 2013 | 78 | 0.370 |
Why?
| | Blood Glucose | 10 | 2019 | 2273 | 0.370 |
Why?
| | Feeding Behavior | 5 | 2025 | 679 | 0.360 |
Why?
| | Pregnancy | 9 | 2023 | 7035 | 0.360 |
Why?
| | Recurrence | 4 | 2019 | 1104 | 0.350 |
Why?
| | Diabetes Mellitus | 6 | 2018 | 1072 | 0.350 |
Why?
| | Estrous Cycle | 1 | 2010 | 20 | 0.330 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 336 | 0.330 |
Why?
| | Body Mass Index | 11 | 2025 | 2374 | 0.330 |
Why?
| | Lipoproteins | 3 | 2000 | 163 | 0.330 |
Why?
| | Homeostasis | 7 | 2015 | 636 | 0.320 |
Why?
| | Acetyl-CoA Carboxylase | 4 | 2014 | 32 | 0.320 |
Why?
| | RNA, Messenger | 10 | 2019 | 2822 | 0.320 |
Why?
| | Estrogen Receptor alpha | 2 | 2018 | 144 | 0.310 |
Why?
| | Vitamin D | 1 | 2013 | 392 | 0.310 |
Why?
| | Glucose | 10 | 2023 | 1031 | 0.310 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2023 | 22 | 0.300 |
Why?
| | Calorimetry, Indirect | 5 | 2021 | 85 | 0.300 |
Why?
| | National Institutes of Health (U.S.) | 2 | 2023 | 132 | 0.300 |
Why?
| | Huntington Disease | 2 | 2021 | 64 | 0.290 |
Why?
| | Dietary Carbohydrates | 5 | 2019 | 152 | 0.290 |
Why?
| | Behavior Therapy | 2 | 2021 | 282 | 0.280 |
Why?
| | Gastrointestinal Microbiome | 3 | 2023 | 720 | 0.280 |
Why?
| | Time Factors | 10 | 2019 | 6944 | 0.270 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2007 | 33 | 0.270 |
Why?
| | Promoter Regions, Genetic | 5 | 2017 | 1241 | 0.270 |
Why?
| | Mice, Inbred C57BL | 16 | 2025 | 5895 | 0.260 |
Why?
| | Triglycerides | 8 | 2019 | 511 | 0.250 |
Why?
| | Adult | 31 | 2025 | 39134 | 0.250 |
Why?
| | Adiponectin | 5 | 2025 | 243 | 0.250 |
Why?
| | Mammary Glands, Human | 2 | 2020 | 66 | 0.250 |
Why?
| | Leukocytes, Mononuclear | 2 | 2021 | 572 | 0.250 |
Why?
| | Neurons | 1 | 2015 | 1615 | 0.250 |
Why?
| | Antineoplastic Agents | 2 | 2017 | 2156 | 0.250 |
Why?
| | Mice, Knockout | 12 | 2021 | 3064 | 0.250 |
Why?
| | Transplantation, Autologous | 1 | 2007 | 280 | 0.250 |
Why?
| | Dehydration | 2 | 2016 | 54 | 0.240 |
Why?
| | Lymphoma | 1 | 2007 | 228 | 0.240 |
Why?
| | Adenocarcinoma | 1 | 2012 | 895 | 0.230 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2023 | 2524 | 0.230 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 180 | 0.230 |
Why?
| | Feces | 4 | 2023 | 493 | 0.230 |
Why?
| | Epithelium | 2 | 2019 | 315 | 0.230 |
Why?
| | Signal Transduction | 6 | 2022 | 5148 | 0.230 |
Why?
| | Muscle Proteins | 4 | 2012 | 236 | 0.230 |
Why?
| | Metabolic Syndrome | 3 | 2021 | 348 | 0.230 |
Why?
| | Sheep | 3 | 2023 | 872 | 0.220 |
Why?
| | Leukemia | 1 | 2007 | 243 | 0.220 |
Why?
| | Photoperiod | 2 | 2019 | 53 | 0.220 |
Why?
| | Hematopoietic Stem Cells | 2 | 2025 | 411 | 0.220 |
Why?
| | Transcriptome | 3 | 2024 | 1007 | 0.220 |
Why?
| | DNA-Binding Proteins | 7 | 2019 | 1478 | 0.210 |
Why?
| | Multiple Myeloma | 1 | 2007 | 282 | 0.210 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 43 | 0.210 |
Why?
| | Physical Fitness | 2 | 2016 | 206 | 0.210 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2019 | 270 | 0.210 |
Why?
| | Animals, Newborn | 3 | 2017 | 866 | 0.210 |
Why?
| | Cholesterol Ester Transfer Proteins | 5 | 2005 | 19 | 0.200 |
Why?
| | Resistance Training | 3 | 2017 | 168 | 0.200 |
Why?
| | Arteriosclerosis | 1 | 2003 | 83 | 0.200 |
Why?
| | Financing, Organized | 1 | 2023 | 36 | 0.200 |
Why?
| | Fetal Development | 2 | 2023 | 296 | 0.200 |
Why?
| | Transcriptional Activation | 2 | 2002 | 377 | 0.200 |
Why?
| | Animal Feed | 3 | 2019 | 53 | 0.200 |
Why?
| | Sequence Analysis, RNA | 3 | 2021 | 447 | 0.200 |
Why?
| | Hospitalization | 1 | 2013 | 2261 | 0.200 |
Why?
| | Ghrelin | 3 | 2025 | 36 | 0.190 |
Why?
| | Cell Proliferation | 3 | 2017 | 2497 | 0.190 |
Why?
| | Parturition | 1 | 2023 | 67 | 0.190 |
Why?
| | Oxidation-Reduction | 6 | 2019 | 1086 | 0.190 |
Why?
| | Tamoxifen | 3 | 2021 | 203 | 0.180 |
Why?
| | Postmenopause | 4 | 2022 | 369 | 0.180 |
Why?
| | Exercise Tolerance | 3 | 2016 | 280 | 0.180 |
Why?
| | Faculty | 1 | 2023 | 153 | 0.180 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 56 | 0.180 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1430 | 0.180 |
Why?
| | Malus | 1 | 2021 | 12 | 0.170 |
Why?
| | Polyphenols | 1 | 2021 | 20 | 0.170 |
Why?
| | Middle Aged | 22 | 2025 | 34487 | 0.170 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 20 | 0.170 |
Why?
| | Mentors | 1 | 2023 | 212 | 0.170 |
Why?
| | Thinness | 3 | 2021 | 95 | 0.170 |
Why?
| | Hygromycin B | 1 | 2000 | 3 | 0.170 |
Why?
| | Liver X Receptors | 2 | 2019 | 30 | 0.170 |
Why?
| | Disease Progression | 4 | 2018 | 2791 | 0.170 |
Why?
| | Cinnamates | 1 | 2000 | 12 | 0.170 |
Why?
| | Child Development | 2 | 2018 | 496 | 0.170 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2021 | 170 | 0.170 |
Why?
| | Hyperinsulinism | 1 | 2001 | 114 | 0.160 |
Why?
| | Kynurenine 3-Monooxygenase | 1 | 2020 | 5 | 0.160 |
Why?
| | Fruit | 1 | 2021 | 146 | 0.160 |
Why?
| | Kynurenic Acid | 1 | 2020 | 18 | 0.160 |
Why?
| | Random Allocation | 2 | 2019 | 363 | 0.160 |
Why?
| | Transcription, Genetic | 7 | 2017 | 1485 | 0.160 |
Why?
| | Starch | 1 | 2019 | 22 | 0.160 |
Why?
| | Nutritive Value | 1 | 2019 | 36 | 0.160 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 428 | 0.150 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 17 | 0.150 |
Why?
| | Cattle | 2 | 2019 | 991 | 0.150 |
Why?
| | Weaning | 1 | 2019 | 46 | 0.150 |
Why?
| | Membrane Proteins | 3 | 2015 | 1156 | 0.150 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 34 | 0.150 |
Why?
| | Metabolic Diseases | 2 | 2018 | 114 | 0.150 |
Why?
| | Analysis of Variance | 4 | 2016 | 1313 | 0.150 |
Why?
| | Retinal Ganglion Cells | 1 | 2020 | 117 | 0.150 |
Why?
| | Gene Expression Profiling | 2 | 2018 | 1761 | 0.150 |
Why?
| | Rats, Sprague-Dawley | 8 | 2015 | 2522 | 0.140 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2020 | 196 | 0.140 |
Why?
| | Mice, Transgenic | 7 | 2017 | 2176 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2018 | 45 | 0.140 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 46 | 0.140 |
Why?
| | Aromatase | 1 | 2018 | 31 | 0.140 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2018 | 33 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 151 | 0.140 |
Why?
| | Glycogen | 6 | 2010 | 54 | 0.140 |
Why?
| | Perilipin-1 | 1 | 2017 | 17 | 0.140 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 31 | 0.140 |
Why?
| | Rest | 1 | 2018 | 128 | 0.140 |
Why?
| | Postpartum Period | 2 | 2020 | 343 | 0.140 |
Why?
| | Models, Animal | 1 | 2019 | 393 | 0.140 |
Why?
| | Diglycerides | 1 | 2018 | 60 | 0.140 |
Why?
| | Cell Size | 1 | 2017 | 89 | 0.140 |
Why?
| | Fetal Growth Retardation | 1 | 2023 | 582 | 0.140 |
Why?
| | Germ Layers | 1 | 2017 | 6 | 0.130 |
Why?
| | Gastrulation | 1 | 2017 | 9 | 0.130 |
Why?
| | Urea | 1 | 2017 | 81 | 0.130 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 71 | 0.130 |
Why?
| | Sucrose | 2 | 2018 | 111 | 0.130 |
Why?
| | Sphingolipids | 1 | 2018 | 80 | 0.130 |
Why?
| | Organic Cation Transporter 2 | 1 | 2017 | 8 | 0.130 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 699 | 0.130 |
Why?
| | Reperfusion Injury | 1 | 2020 | 292 | 0.130 |
Why?
| | Running | 1 | 2019 | 232 | 0.130 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 63 | 0.130 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 14 | 0.130 |
Why?
| | Chromatography, Gas | 1 | 2016 | 33 | 0.130 |
Why?
| | Interdisciplinary Communication | 1 | 2018 | 191 | 0.130 |
Why?
| | Neural Pathways | 2 | 2011 | 303 | 0.130 |
Why?
| | Glaucoma | 1 | 2020 | 241 | 0.130 |
Why?
| | Dogs | 1 | 2018 | 426 | 0.130 |
Why?
| | Dyslipidemias | 1 | 2018 | 175 | 0.130 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 98 | 0.130 |
Why?
| | PPAR gamma | 1 | 2017 | 178 | 0.130 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 318 | 0.120 |
Why?
| | Alloxan | 1 | 2015 | 4 | 0.120 |
Why?
| | Receptors, Androgen | 1 | 2017 | 153 | 0.120 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 4 | 2019 | 56 | 0.120 |
Why?
| | Corpus Striatum | 1 | 2017 | 174 | 0.120 |
Why?
| | Hypothalamus | 1 | 2016 | 154 | 0.120 |
Why?
| | Obesity, Morbid | 1 | 2000 | 273 | 0.120 |
Why?
| | Glucokinase | 1 | 2015 | 15 | 0.120 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 15 | 0.120 |
Why?
| | Fibroblasts | 2 | 2017 | 1017 | 0.120 |
Why?
| | Computational Biology | 1 | 2020 | 664 | 0.120 |
Why?
| | Down-Regulation | 3 | 2008 | 638 | 0.120 |
Why?
| | Malonyl Coenzyme A | 1 | 1995 | 5 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 758 | 0.120 |
Why?
| | Methylnitrosourea | 2 | 2018 | 7 | 0.120 |
Why?
| | Pediatric Obesity | 1 | 2022 | 599 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2023 | 805 | 0.110 |
Why?
| | Cholesterol, LDL | 3 | 2003 | 360 | 0.110 |
Why?
| | Trophoblasts | 1 | 2017 | 210 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 263 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 463 | 0.110 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1093 | 0.110 |
Why?
| | Caffeine | 1 | 1995 | 74 | 0.110 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 512 | 0.110 |
Why?
| | Research Report | 1 | 2014 | 80 | 0.110 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 265 | 0.110 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 2 | 2005 | 37 | 0.110 |
Why?
| | Infant | 5 | 2023 | 9790 | 0.110 |
Why?
| | Acinar Cells | 1 | 2013 | 13 | 0.100 |
Why?
| | United States | 3 | 2023 | 15195 | 0.100 |
Why?
| | Pantothenic Acid | 1 | 2013 | 5 | 0.100 |
Why?
| | Bariatric Surgery | 1 | 2017 | 218 | 0.100 |
Why?
| | Mitochondria | 3 | 2022 | 974 | 0.100 |
Why?
| | Birth Weight | 1 | 2016 | 511 | 0.100 |
Why?
| | Mitochondria, Liver | 1 | 2013 | 70 | 0.100 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1726 | 0.100 |
Why?
| | Vitamin A Deficiency | 1 | 2013 | 26 | 0.100 |
Why?
| | Vitamin A | 1 | 2013 | 56 | 0.100 |
Why?
| | Circadian Rhythm | 2 | 2009 | 509 | 0.100 |
Why?
| | Extracellular Space | 1 | 2013 | 129 | 0.100 |
Why?
| | Integrases | 1 | 2013 | 123 | 0.100 |
Why?
| | Intestinal Mucosa | 2 | 2015 | 628 | 0.100 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 7 | 0.100 |
Why?
| | DNA Methylation | 1 | 2017 | 640 | 0.090 |
Why?
| | Oxidative Phosphorylation | 1 | 2013 | 204 | 0.090 |
Why?
| | Cell Separation | 1 | 2013 | 317 | 0.090 |
Why?
| | Up-Regulation | 2 | 2013 | 856 | 0.090 |
Why?
| | Cytoskeleton | 1 | 2013 | 194 | 0.090 |
Why?
| | Hormones | 2 | 2010 | 138 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 873 | 0.090 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 842 | 0.090 |
Why?
| | Histones | 1 | 2017 | 638 | 0.090 |
Why?
| | Epithelial Cells | 2 | 2020 | 1113 | 0.090 |
Why?
| | Research Design | 1 | 2018 | 1104 | 0.090 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 2002 | 36 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 171 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2013 | 306 | 0.090 |
Why?
| | Biomarkers | 6 | 2019 | 4175 | 0.090 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2082 | 0.090 |
Why?
| | Multienzyme Complexes | 2 | 2001 | 66 | 0.090 |
Why?
| | Vitamin D Deficiency | 1 | 2013 | 187 | 0.090 |
Why?
| | Glycolysis | 1 | 2012 | 326 | 0.080 |
Why?
| | Pulmonary Alveoli | 1 | 2013 | 413 | 0.080 |
Why?
| | Colon | 1 | 2013 | 296 | 0.080 |
Why?
| | Infant, Newborn | 3 | 2018 | 6257 | 0.080 |
Why?
| | Lipoproteins, VLDL | 2 | 2000 | 19 | 0.080 |
Why?
| | Patient Compliance | 1 | 2014 | 607 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 368 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4597 | 0.080 |
Why?
| | Metalloproteases | 1 | 2010 | 43 | 0.080 |
Why?
| | Perilipin-2 | 3 | 2015 | 41 | 0.080 |
Why?
| | Acetaminophen | 1 | 2012 | 264 | 0.080 |
Why?
| | Bone and Bones | 1 | 2012 | 313 | 0.080 |
Why?
| | Alkylating Agents | 1 | 2009 | 24 | 0.080 |
Why?
| | Mitochondrial Proteins | 2 | 2010 | 260 | 0.080 |
Why?
| | Species Specificity | 1 | 2011 | 577 | 0.080 |
Why?
| | Hypertension | 1 | 2018 | 1251 | 0.080 |
Why?
| | Fats | 1 | 2009 | 18 | 0.080 |
Why?
| | Cholesterol, HDL | 2 | 2000 | 196 | 0.080 |
Why?
| | Glucose Clamp Technique | 2 | 2018 | 197 | 0.070 |
Why?
| | Adolescent | 6 | 2025 | 22027 | 0.070 |
Why?
| | Young Adult | 6 | 2025 | 13646 | 0.070 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 150 | 0.070 |
Why?
| | Health Behavior | 1 | 2014 | 783 | 0.070 |
Why?
| | Interleukin-4 | 1 | 2009 | 215 | 0.070 |
Why?
| | Hypoglycemic Agents | 2 | 2017 | 1368 | 0.070 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2013 | 359 | 0.070 |
Why?
| | Self Report | 1 | 2013 | 858 | 0.070 |
Why?
| | Disease Susceptibility | 3 | 2016 | 352 | 0.070 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2014 | 197 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2368 | 0.070 |
Why?
| | Interleukin-2 | 1 | 2009 | 451 | 0.070 |
Why?
| | Cross-Over Studies | 2 | 2021 | 577 | 0.070 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2007 | 27 | 0.070 |
Why?
| | Hyperplasia | 1 | 2008 | 174 | 0.070 |
Why?
| | Phosphorylation | 2 | 2012 | 1758 | 0.070 |
Why?
| | Risk Factors | 3 | 2018 | 10430 | 0.070 |
Why?
| | Antigens, CD34 | 1 | 2007 | 89 | 0.070 |
Why?
| | Treatment Outcome | 3 | 2016 | 11125 | 0.070 |
Why?
| | Metabolic Networks and Pathways | 2 | 2022 | 184 | 0.060 |
Why?
| | Patient Selection | 2 | 2009 | 684 | 0.060 |
Why?
| | Body Temperature Regulation | 1 | 2008 | 102 | 0.060 |
Why?
| | Leukocyte Count | 1 | 2007 | 328 | 0.060 |
Why?
| | Cell Line | 3 | 2019 | 2879 | 0.060 |
Why?
| | Lactates | 3 | 1995 | 85 | 0.060 |
Why?
| | Exercise Test | 1 | 2009 | 623 | 0.060 |
Why?
| | Transplantation Conditioning | 1 | 2007 | 184 | 0.060 |
Why?
| | Calorimetry | 3 | 2012 | 71 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2022 | 777 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 61 | 0.060 |
Why?
| | Gluconeogenesis | 1 | 2006 | 78 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 803 | 0.060 |
Why?
| | Peptide YY | 1 | 2025 | 17 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 1999 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1598 | 0.060 |
Why?
| | Glucose Transporter Type 4 | 2 | 2002 | 38 | 0.060 |
Why?
| | Sterol Regulatory Element Binding Protein 2 | 1 | 2005 | 7 | 0.060 |
Why?
| | Lipolysis | 1 | 2005 | 46 | 0.060 |
Why?
| | Retrospective Studies | 3 | 2018 | 16315 | 0.060 |
Why?
| | Models, Biological | 2 | 2018 | 1822 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2019 | 3578 | 0.060 |
Why?
| | Proteomics | 2 | 2022 | 1136 | 0.060 |
Why?
| | Proteins | 2 | 2013 | 1013 | 0.060 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 208 | 0.050 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2025 | 140 | 0.050 |
Why?
| | Macrophages | 1 | 2012 | 1559 | 0.050 |
Why?
| | Kinetics | 2 | 2012 | 1651 | 0.050 |
Why?
| | Antigens, CD | 1 | 2007 | 544 | 0.050 |
Why?
| | Myogenic Regulatory Factors | 2 | 2001 | 45 | 0.050 |
Why?
| | Organ Specificity | 1 | 2005 | 311 | 0.050 |
Why?
| | Pilot Projects | 2 | 2022 | 1815 | 0.050 |
Why?
| | MEF2 Transcription Factors | 2 | 2001 | 50 | 0.050 |
Why?
| | Cholesterol, VLDL | 1 | 2003 | 5 | 0.050 |
Why?
| | RNA, Small Interfering | 1 | 2006 | 624 | 0.050 |
Why?
| | Endoplasmic Reticulum | 2 | 2018 | 263 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 389 | 0.050 |
Why?
| | Food Deprivation | 1 | 2003 | 27 | 0.050 |
Why?
| | Protein Kinases | 2 | 2002 | 308 | 0.050 |
Why?
| | Occult Blood | 1 | 2023 | 37 | 0.050 |
Why?
| | Hexokinase | 1 | 2022 | 17 | 0.050 |
Why?
| | Absorptiometry, Photon | 1 | 2004 | 265 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 21 | 0.050 |
Why?
| | Ethers | 1 | 2022 | 19 | 0.050 |
Why?
| | Aged | 5 | 2018 | 24666 | 0.050 |
Why?
| | Lactic Acid | 4 | 2002 | 303 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2022 | 112 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 52 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2022 | 76 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2062 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 89 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 117 | 0.050 |
Why?
| | Rodentia | 1 | 2022 | 59 | 0.050 |
Why?
| | Subcutaneous Fat | 1 | 2022 | 81 | 0.050 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 65 | 0.050 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2013 | 41 | 0.050 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2022 | 131 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2022 | 86 | 0.050 |
Why?
| | Dinoprostone | 1 | 2022 | 189 | 0.050 |
Why?
| | Mice, Obese | 1 | 2021 | 66 | 0.050 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2001 | 12 | 0.040 |
Why?
| | Interleukin-13 | 1 | 2022 | 149 | 0.040 |
Why?
| | Diabetes Complications | 1 | 2003 | 222 | 0.040 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 58 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2022 | 272 | 0.040 |
Why?
| | Neutrophils | 1 | 2007 | 1282 | 0.040 |
Why?
| | Waist Circumference | 1 | 2021 | 133 | 0.040 |
Why?
| | Tumor Burden | 1 | 2022 | 310 | 0.040 |
Why?
| | Phospholipids | 1 | 2022 | 221 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2021 | 71 | 0.040 |
Why?
| | Drinking | 1 | 2021 | 42 | 0.040 |
Why?
| | Intestines | 2 | 2015 | 355 | 0.040 |
Why?
| | Hemoglobins | 1 | 2023 | 361 | 0.040 |
Why?
| | Blotting, Southern | 1 | 2000 | 75 | 0.040 |
Why?
| | Colonoscopy | 1 | 2023 | 250 | 0.040 |
Why?
| | Calmodulin | 1 | 2000 | 71 | 0.040 |
Why?
| | Hindlimb | 3 | 1995 | 134 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2022 | 737 | 0.040 |
Why?
| | Calcineurin | 1 | 2000 | 107 | 0.040 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2020 | 105 | 0.040 |
Why?
| | Lipoproteins, HDL | 1 | 2000 | 78 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2000 | 272 | 0.040 |
Why?
| | Lipoproteins, LDL | 1 | 2000 | 112 | 0.040 |
Why?
| | Medicago sativa | 1 | 2019 | 3 | 0.040 |
Why?
| | Rumen | 1 | 2019 | 7 | 0.040 |
Why?
| | Dairying | 1 | 2019 | 8 | 0.040 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2019 | 17 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2018 | 7899 | 0.040 |
Why?
| | Benzylamines | 1 | 2019 | 44 | 0.040 |
Why?
| | New Zealand | 1 | 2019 | 55 | 0.040 |
Why?
| | Protein Kinase C | 1 | 2000 | 252 | 0.040 |
Why?
| | Benzoates | 1 | 2019 | 49 | 0.040 |
Why?
| | Postprandial Period | 1 | 2019 | 111 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2019 | 214 | 0.040 |
Why?
| | Child | 2 | 2022 | 22313 | 0.040 |
Why?
| | Mathematical Concepts | 1 | 2018 | 33 | 0.040 |
Why?
| | Prospective Studies | 2 | 2023 | 7749 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2019 | 135 | 0.040 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2019 | 120 | 0.040 |
Why?
| | Japan | 1 | 2018 | 132 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5645 | 0.040 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 430 | 0.040 |
Why?
| | Huntingtin Protein | 1 | 2017 | 13 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2023 | 1968 | 0.030 |
Why?
| | Transfection | 1 | 2000 | 936 | 0.030 |
Why?
| | Sarcolemma | 1 | 2018 | 42 | 0.030 |
Why?
| | Stromal Cells | 1 | 2018 | 116 | 0.030 |
Why?
| | Nuclear Transfer Techniques | 1 | 2017 | 3 | 0.030 |
Why?
| | Trinucleotide Repeat Expansion | 1 | 2017 | 44 | 0.030 |
Why?
| | Comparative Genomic Hybridization | 1 | 2017 | 29 | 0.030 |
Why?
| | Estrogen Replacement Therapy | 1 | 1998 | 142 | 0.030 |
Why?
| | Cytokines | 2 | 2018 | 2092 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2000 | 672 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 337 | 0.030 |
Why?
| | Muscle Contraction | 1 | 2000 | 435 | 0.030 |
Why?
| | Blastocyst | 1 | 2017 | 47 | 0.030 |
Why?
| | Breast | 1 | 2018 | 155 | 0.030 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 27 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1241 | 0.030 |
Why?
| | Phenylthiohydantoin | 1 | 2017 | 44 | 0.030 |
Why?
| | Cyclic AMP | 2 | 1995 | 219 | 0.030 |
Why?
| | Neoplasms | 1 | 2012 | 2718 | 0.030 |
Why?
| | Biological Specimen Banks | 1 | 2018 | 99 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2000 | 614 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 164 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 229 | 0.030 |
Why?
| | Brain | 2 | 2021 | 2852 | 0.030 |
Why?
| | Isoenzymes | 2 | 2012 | 301 | 0.030 |
Why?
| | Meat | 1 | 2018 | 93 | 0.030 |
Why?
| | Water Deprivation | 1 | 2016 | 5 | 0.030 |
Why?
| | Erythrocytes | 1 | 2022 | 707 | 0.030 |
Why?
| | Ectoderm | 1 | 2017 | 53 | 0.030 |
Why?
| | Animals, Genetically Modified | 1 | 2017 | 242 | 0.030 |
Why?
| | Methylation | 1 | 2017 | 230 | 0.030 |
Why?
| | Fertilization in Vitro | 1 | 2017 | 85 | 0.030 |
Why?
| | Epinephrine | 2 | 1994 | 148 | 0.030 |
Why?
| | Progesterone | 1 | 1998 | 258 | 0.030 |
Why?
| | Nutrition Surveys | 1 | 2018 | 280 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2017 | 197 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1195 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 367 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 157 | 0.030 |
Why?
| | Steroids | 1 | 2017 | 163 | 0.030 |
Why?
| | Benzamides | 1 | 2017 | 220 | 0.030 |
Why?
| | Nitriles | 1 | 2017 | 188 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 603 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 121 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 854 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2017 | 185 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 453 | 0.030 |
Why?
| | Phosphocreatine | 1 | 1995 | 45 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1325 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 1978 | 0.030 |
Why?
| | Adenosine Monophosphate | 1 | 1995 | 73 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4199 | 0.030 |
Why?
| | Fructosediphosphates | 1 | 1994 | 1 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 23 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1190 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 851 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1069 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2014 | 340 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 740 | 0.030 |
Why?
| | Perfusion | 1 | 1995 | 228 | 0.030 |
Why?
| | Lipids | 1 | 1998 | 689 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Hot Temperature | 1 | 2016 | 406 | 0.030 |
Why?
| | Testosterone | 1 | 2017 | 404 | 0.030 |
Why?
| | Cell Respiration | 1 | 2013 | 106 | 0.030 |
Why?
| | Laser Capture Microdissection | 1 | 2013 | 32 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3336 | 0.030 |
Why?
| | Betaine | 1 | 2013 | 65 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 86 | 0.020 |
Why?
| | Muscles | 1 | 1994 | 333 | 0.020 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 545 | 0.020 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2002 | 158 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 655 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 2051 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2012 | 149 | 0.020 |
Why?
| | Intestine, Small | 1 | 2013 | 157 | 0.020 |
Why?
| | Collagen Type I | 1 | 2012 | 140 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1745 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2780 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 757 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 310 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2920 | 0.020 |
Why?
| | Metabolism | 1 | 2010 | 43 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2013 | 517 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2000 | 1856 | 0.020 |
Why?
| | Glycerol | 1 | 2009 | 91 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3487 | 0.020 |
Why?
| | Liver Glycogen | 2 | 2002 | 16 | 0.020 |
Why?
| | Hypoglycemia | 1 | 1994 | 467 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3484 | 0.020 |
Why?
| | Proteome | 1 | 2013 | 483 | 0.020 |
Why?
| | Phenotype | 2 | 2008 | 3172 | 0.020 |
Why?
| | Trans-Activators | 1 | 2010 | 394 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2010 | 632 | 0.020 |
Why?
| | Birds | 1 | 2008 | 100 | 0.020 |
Why?
| | Body Temperature | 1 | 2008 | 224 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 979 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 31 | 0.020 |
Why?
| | Palmitates | 1 | 2006 | 21 | 0.020 |
Why?
| | Orphan Nuclear Receptors | 1 | 2006 | 14 | 0.020 |
Why?
| | Breeding | 1 | 2006 | 65 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2006 | 32 | 0.020 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2006 | 30 | 0.020 |
Why?
| | PPAR alpha | 1 | 2006 | 57 | 0.020 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 31 | 0.020 |
Why?
| | Intestinal Absorption | 1 | 2006 | 92 | 0.020 |
Why?
| | Adenoviridae | 1 | 2006 | 200 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2006 | 241 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 2006 | 201 | 0.010 |
Why?
| | Introns | 1 | 2005 | 253 | 0.010 |
Why?
| | Enzymes | 1 | 2003 | 65 | 0.010 |
Why?
| | Uncoupling Protein 3 | 1 | 2002 | 8 | 0.010 |
Why?
| | Oxazoles | 1 | 2002 | 46 | 0.010 |
Why?
| | Ketones | 1 | 2002 | 51 | 0.010 |
Why?
| | Thiazoles | 1 | 2002 | 134 | 0.010 |
Why?
| | Ribonucleotides | 1 | 2001 | 26 | 0.010 |
Why?
| | Ion Channels | 1 | 2002 | 130 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2891 | 0.010 |
Why?
| | Tyrosine | 1 | 2002 | 228 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 801 | 0.010 |
Why?
| | Aging | 1 | 2010 | 1917 | 0.010 |
Why?
| | RNA | 1 | 2003 | 929 | 0.010 |
Why?
| | Administration, Oral | 1 | 1998 | 802 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 9 | 0.010 |
Why?
| | Molecular Weight | 1 | 1995 | 327 | 0.010 |
Why?
| | Phosphofructokinase-1 | 1 | 1994 | 6 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 335 | 0.010 |
Why?
| | Cyclic GMP | 1 | 1994 | 91 | 0.010 |
Why?
| | Age Factors | 1 | 2000 | 3278 | 0.010 |
Why?
| | Blotting, Western | 1 | 1995 | 1231 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1994 | 498 | 0.010 |
Why?
|
|
MacLean's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|